ED
43
-2
ECL
59
-3
XRX
37
3
ZBH
62
-3
MAR
69
-3
EXR
55
-4
OXY
52
-3
IRM
39
-3
FDX
44
-10
UNH
60
-3
GD
46
-13
MTCH
30
8
NOC
34
-6
DE
39
3
FAST
61
-3
LRCX
48
2
NDAQ
59
-4
M
36
5
EW
29
-3
RIG
50
6
ED
43
-2
ECL
59
-3
XRX
37
3
ZBH
62
-3
MAR
69
-3
EXR
55
-4
OXY
52
-3
IRM
39
-3
FDX
44
-10
UNH
60
-3
GD
46
-13
MTCH
30
8
NOC
34
-6
DE
39
3
FAST
61
-3
LRCX
48
2
NDAQ
59
-4
M
36
5
EW
29
-3
RIG
50
6
Financhill
Back

JPMorgan Carbon Transition US Eq ETF Vs. Dyne Therapeutics Industry Stock Comparison

Buy
67

JCTR
JPMorgan Carbon Transition US Eq ETF

Last Price:
81.11
Seasonality Move:
6.45%
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Buy
67
JPMorgan Carbon Transition US Eq ETF (JCTR) is a Buy

Is JPMorgan Carbon Transition US Eq ETF a Buy, Sell or Hold?

  • The current JPMorgan Carbon Transition US Eq ETF [JCTR] share price is $81.06. The Score for JCTR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • JCTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JCTR Stock Price Chart

What is JPMorgan Carbon Transition US Eq ETF's stock price today?

  • The JPMorgan Carbon Transition US Eq ETF share price today is $81.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JCTR is experiencing slight buying pressure.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

JCTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.95 Buy
Relative Strength Index (14 RSI): 69.73 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.66 - 80.3) Buy
Bollinger Bands (100): (73.32 - 78.38) Buy

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

JCTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.49 Buy
20-day SMA: 79.05 Buy
50-day SMA: 77.7 Buy
200-day SMA: 72.88 Buy
8-day EMA: 80.41 Buy
20-day EMA: 79.37 Buy
50-day EMA: 77.88 Buy
200-day EMA: 72.84 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

JPMorgan Carbon Transition US Eq ETF Earnings Growth & JCTR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

JPMorgan Carbon Transition US Eq ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):